お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
978784

バーチャル臨床試験の世界市場 - 業界分析と予測:2020年~2026年

Global Virtual Clinical Trials Market By Study Type, By Indication, By Region, Industry Analysis and Forecast, 2020 - 2026

出版日: | 発行: KBV Research | ページ情報: 英文 196 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.13円
バーチャル臨床試験の世界市場 - 業界分析と予測:2020年~2026年
出版日: 2020年12月15日
発行: KBV Research
ページ情報: 英文 196 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバーチャル臨床試験の市場規模は、2026年までに100億米ドルに達し、予測期間中のCAGRで6.5%の成長が予測されています。市場は、研究開発活動の成長、医療のデジタル化の進展、遠隔医療の採用によって大きく牽引されています。さらに、技術の進歩、臨床研究企業・バイオテクノロジー企業・製薬会社間の協力、政府による支援イニシアチブが、市場を後押しすることが期待されています。

当レポートでは、世界のバーチャル臨床試験市場について調査分析し、市場概要、市場規模・予測、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 市場範囲と調査手法

第2章 市場概要

  • イントロダクション
  • 市場に影響を与える主な要因

第3章 競合分析:世界

  • マトリクス
  • 最近の業界全体の戦略的発展
  • 主要成功戦略

第4章 世界のバーチャル臨床試験市場:試験タイプ別

  • 介入
  • 観察
  • 拡張アクセス

第5章 世界のバーチャル臨床試験市場:適応症別

  • 腫瘍
  • 心血管
  • 免疫
  • 胃腸
  • 呼吸器
  • 内分泌
  • 眼科
  • その他

第6章 世界のバーチャル臨床試験市場:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ

第7章 企業プロファイル

  • IQVIA Holdings, Inc.
  • ICON PLC
  • Laboratory Corporation of America Holdings (Covance, Inc.)
  • Dassault Systemes SE (Medidata Solutions, Inc.)
  • Oracle Corporation
  • Parexel International Corporation (Pamplona Capital Management)
  • PRA Health Sciences, Inc. (KKR & Co., Inc.)
  • Medpace Holdings, Inc.
  • Medable, Inc.
  • Clinical Ink, Inc. (G.I. Partners)
図表

LIST OF TABLES

  • TABLE 1 GLOBAL VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 GLOBAL VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- VIRTUAL CLINICAL TRIALS MARKET
  • TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- VIRTUAL CLINICAL TRIALS MARKET
  • TABLE 5 GEOGRAPHICAL EXPANSIONS - VIRTUAL CLINICAL TRIALS MARKET
  • TABLE 6 ACQUISITION AND MERGERS- VIRTUAL CLINICAL TRIALS MARKET
  • TABLE 7 GLOBAL VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 8 GLOBAL VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 9 GLOBAL INTERVENTIONAL MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 10 GLOBAL INTERVENTIONAL MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 11 GLOBAL OBSERVATIONAL MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 12 GLOBAL OBSERVATIONAL MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 13 GLOBAL EXPANDED ACCESS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 14 GLOBAL EXPANDED ACCESS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 15 GLOBAL VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 16 GLOBAL VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 17 GLOBAL ONCOLOGY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 18 GLOBAL ONCOLOGY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 19 GLOBAL CARDIOVASCULAR MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 20 GLOBAL CARDIOVASCULAR MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 21 GLOBAL IMMUNOLOGY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 22 GLOBAL IMMUNOLOGY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 23 GLOBAL GASTROINTESTINAL MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 24 GLOBAL GASTROINTESTINAL MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 25 GLOBAL RESPIRATORY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 26 GLOBAL RESPIRATORY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 27 GLOBAL ENDOCRINOLOGY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 28 GLOBAL ENDOCRINOLOGY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 29 GLOBAL OPHTHALMOLOGY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 30 GLOBAL OPHTHALMOLOGY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 31 GLOBAL OTHER INDICATIONS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 32 GLOBAL OTHER INDICATIONS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 33 GLOBAL VIRTUAL CLINICAL TRIALS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 34 GLOBAL VIRTUAL CLINICAL TRIALS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 35 NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 36 NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 37 NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 38 NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 39 NORTH AMERICA INTERVENTIONAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 40 NORTH AMERICA INTERVENTIONAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 41 NORTH AMERICA OBSERVATIONAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 42 NORTH AMERICA OBSERVATIONAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 43 NORTH AMERICA EXPANDED ACCESS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 44 NORTH AMERICA EXPANDED ACCESS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 45 NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 46 NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 47 NORTH AMERICA ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 48 NORTH AMERICA ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 49 NORTH AMERICA CARDIOVASCULAR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 50 NORTH AMERICA CARDIOVASCULAR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 51 NORTH AMERICA IMMUNOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 52 NORTH AMERICA IMMUNOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 53 NORTH AMERICA GASTROINTESTINAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 54 NORTH AMERICA GASTROINTESTINAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 55 NORTH AMERICA RESPIRATORY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 56 NORTH AMERICA RESPIRATORY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 57 NORTH AMERICA ENDOCRINOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 58 NORTH AMERICA ENDOCRINOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 59 NORTH AMERICA OPHTHALMOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 60 NORTH AMERICA OPHTHALMOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 61 NORTH AMERICA OTHER INDICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 62 NORTH AMERICA OTHER INDICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 63 NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 64 NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 65 US VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 66 US VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 67 US VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 68 US VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 69 US VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 70 US VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 71 CANADA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 72 CANADA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 73 CANADA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 74 CANADA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 75 CANADA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 76 CANADA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 77 MEXICO VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 78 MEXICO VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 79 MEXICO VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 80 MEXICO VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 81 MEXICO VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 82 MEXICO VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 83 REST OF NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 84 REST OF NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 85 REST OF NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 86 REST OF NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 87 REST OF NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 88 REST OF NORTH AMERICA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 89 EUROPE VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 90 EUROPE VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 91 EUROPE VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 92 EUROPE VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 93 EUROPE INTERVENTIONAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 94 EUROPE INTERVENTIONAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 95 EUROPE OBSERVATIONAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 96 EUROPE OBSERVATIONAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 97 EUROPE EXPANDED ACCESS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 98 EUROPE EXPANDED ACCESS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 99 EUROPE VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 100 EUROPE VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 101 EUROPE ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 102 EUROPE ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 103 EUROPE CARDIOVASCULAR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 104 EUROPE CARDIOVASCULAR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 105 EUROPE IMMUNOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 106 EUROPE IMMUNOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 107 EUROPE GASTROINTESTINAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 108 EUROPE GASTROINTESTINAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 109 EUROPE RESPIRATORY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 110 EUROPE RESPIRATORY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 111 EUROPE ENDOCRINOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 112 EUROPE ENDOCRINOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 113 EUROPE OPHTHALMOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 114 EUROPE OPHTHALMOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 115 EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 116 EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 117 EUROPE VIRTUAL CLINICAL TRIALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 118 EUROPE VIRTUAL CLINICAL TRIALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 119 GERMANY VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 120 GERMANY VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 121 GERMANY VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 122 GERMANY VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 123 GERMANY VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 124 GERMANY VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 125 UK VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 126 UK VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 127 UK VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 128 UK VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 129 UK VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 130 UK VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 131 FRANCE VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 132 FRANCE VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 133 FRANCE VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 134 FRANCE VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 135 FRANCE VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 136 FRANCE VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 137 RUSSIA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 138 RUSSIA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 139 RUSSIA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 140 RUSSIA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 141 RUSSIA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 142 RUSSIA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 143 SPAIN VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 144 SPAIN VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 145 SPAIN VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 146 SPAIN VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 147 SPAIN VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 148 SPAIN VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 149 ITALY VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 150 ITALY VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 151 ITALY VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 152 ITALY VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 153 ITALY VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 154 ITALY VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 155 REST OF EUROPE VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 156 REST OF EUROPE VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 157 REST OF EUROPE VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 158 REST OF EUROPE VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 159 REST OF EUROPE VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 160 REST OF EUROPE VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 161 ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 162 ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 163 ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 164 ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 165 ASIA PACIFIC INTERVENTIONAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 166 ASIA PACIFIC INTERVENTIONAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 167 ASIA PACIFIC OBSERVATIONAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 168 ASIA PACIFIC OBSERVATIONAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 169 ASIA PACIFIC EXPANDED ACCESS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 170 ASIA PACIFIC EXPANDED ACCESS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 171 ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 172 ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 173 ASIA PACIFIC ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 174 ASIA PACIFIC ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 175 ASIA PACIFIC CARDIOVASCULAR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 176 ASIA PACIFIC CARDIOVASCULAR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 177 ASIA PACIFIC IMMUNOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 178 ASIA PACIFIC IMMUNOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 179 ASIA PACIFIC GASTROINTESTINAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 180 ASIA PACIFIC GASTROINTESTINAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 181 ASIA PACIFIC RESPIRATORY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 182 ASIA PACIFIC RESPIRATORY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 183 ASIA PACIFIC ENDOCRINOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 184 ASIA PACIFIC ENDOCRINOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 185 ASIA PACIFIC OPHTHALMOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 186 ASIA PACIFIC OPHTHALMOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 187 ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 188 ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 189 ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 190 ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 191 CHINA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 192 CHINA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 193 CHINA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 194 CHINA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 195 CHINA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 196 CHINA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 197 JAPAN VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 198 JAPAN VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 199 JAPAN VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 200 JAPAN VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 201 JAPAN VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 202 JAPAN VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 203 INDIA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 204 INDIA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 205 INDIA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 206 INDIA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 207 INDIA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 208 INDIA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 209 SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 210 SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 211 SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 212 SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 213 SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 214 SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 215 SINGAPORE VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 216 SINGAPORE VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 217 SINGAPORE VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 218 SINGAPORE VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 219 SINGAPORE VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 220 SINGAPORE VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 221 MALAYSIA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 222 MALAYSIA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 223 MALAYSIA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 224 MALAYSIA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 225 MALAYSIA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 226 MALAYSIA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 227 REST OF ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 228 REST OF ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 229 REST OF ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 230 REST OF ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 231 REST OF ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 232 REST OF ASIA PACIFIC VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 233 LAMEA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 234 LAMEA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 235 LAMEA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 236 LAMEA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 237 LAMEA INTERVENTIONAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 238 LAMEA INTERVENTIONAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 239 LAMEA OBSERVATIONAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 240 LAMEA OBSERVATIONAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 241 LAMEA EXPANDED ACCESS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 242 LAMEA EXPANDED ACCESS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 243 LAMEA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 244 LAMEA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 245 LAMEA ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 246 LAMEA ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 247 LAMEA CARDIOVASCULAR MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 248 LAMEA CARDIOVASCULAR MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 249 LAMEA IMMUNOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 250 LAMEA IMMUNOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 251 LAMEA GASTROINTESTINAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 252 LAMEA GASTROINTESTINAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 253 LAMEA RESPIRATORY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 254 LAMEA RESPIRATORY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 255 LAMEA ENDOCRINOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 256 LAMEA ENDOCRINOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 257 LAMEA OPHTHALMOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 258 LAMEA OPHTHALMOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 259 LAMEA OTHER INDICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 260 LAMEA OTHER INDICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 261 LAMEA VIRTUAL CLINICAL TRIALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 262 LAMEA VIRTUAL CLINICAL TRIALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 263 BRAZIL VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 264 BRAZIL VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 265 BRAZIL VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 266 BRAZIL VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 267 BRAZIL VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 268 BRAZIL VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 269 ARGENTINA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 270 ARGENTINA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 271 ARGENTINA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 272 ARGENTINA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 273 ARGENTINA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 274 ARGENTINA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 275 UAE VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 276 UAE VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 277 UAE VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 278 UAE VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 279 UAE VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 280 UAE VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 281 SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 282 SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 283 SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 284 SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 285 SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 286 SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 287 SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 288 SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 289 SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 290 SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 291 SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 292 SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 293 NIGERIA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 294 NIGERIA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 295 NIGERIA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 296 NIGERIA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 297 NIGERIA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 298 NIGERIA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 299 REST OF LAMEA VIRTUAL CLINICAL TRIALS MARKET, 2016 - 2019, USD MILLION
  • TABLE 300 REST OF LAMEA VIRTUAL CLINICAL TRIALS MARKET, 2020 - 2026, USD MILLION
  • TABLE 301 REST OF LAMEA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2016 - 2019, USD MILLION
  • TABLE 302 REST OF LAMEA VIRTUAL CLINICAL TRIALS MARKET BY STUDY TYPE, 2020 - 2026, USD MILLION
  • TABLE 303 REST OF LAMEA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2016 - 2019, USD MILLION
  • TABLE 304 REST OF LAMEA VIRTUAL CLINICAL TRIALS MARKET BY INDICATION, 2020 - 2026, USD MILLION
  • TABLE 305 KEY INFORMATION - IQVIA HOLDINGS, INC.
  • TABLE 306 KEY INFORMATION - ICON PLC
  • TABLE 307 KEY INFORMATION - LABORATORY CORPORATION OF AMERICA HOLDINGS
  • TABLE 308 KEY INFORMATION - DASSAULT SYSTEMES SE
  • TABLE 309 KEY INFORMATION - ORACLE CORPORATION
  • TABLE 310 KEY INFORMATION - PAREXEL INTERNATIONAL CORPORATION
  • TABLE 311 KEY INFORMATION - PRA HEALTH SCIENCES, INC.
  • TABLE 312 KEY INFORMATION - MEDPACE HOLDINGS, INC.
  • TABLE 313 KEY INFORMATION - MEDABLE, INC.
  • TABLE 314 KEY INFORMATION - CLINICAL INK, INC.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
  • FIG 2 KBV CARDINAL MATRIX
  • FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
  • FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS : 2017, FEB - 2020, DEC) LEADING PLAYERS
  • FIG 5 KEY STRATEGIC MOVE: (PRODUCT LAUNCHES AND PRODUCT EXPANSIONS : 2018, JUN - 2020, OCT) LEADING PLAYERS
  • FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: IQVIA HOLDINGS, INC.
  • FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: ICON PLC
  • FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: LABORATORY CORPORATION OF AMERICA
  • FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: DASSAULT SYSTEMES SE
  • FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: ORACLE CORPORATION
  • FIG 11 RECENT STRATEGIES AND DEVELOPMENTS: PAREXEL INTERNATIONAL CORPORATION
  • FIG 12 RECENT STRATEGIES AND DEVELOPMENTS: PRA HEALTH SCIENCES, INC.
  • FIG 13 RECENT STRATEGIES AND DEVELOPMENTS: MEDABLE, INC.
目次

The Global Virtual Clinical Trials Market size is expected to reach $10 billion by 2026, rising at a market growth of 6.5% CAGR during the forecast period. Virtual Clinical Trials (VCTs) are also known as remote or decentralized trails, are a comparatively new but still underused technique of carrying out clinical research taking complete benefit of technologies like apps, online social interaction platforms, and electronic monitoring tools. The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Moreover, advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments are expected to boost the market.

Virtual clinical trials (VCT) abolish limitations presented by conventional clinical trials such as time-taking procedures and delay in recruitment of patients that has pushed the demand for the virtual clinical trial market. Additionally, advances in technology in healthcare infrastructure and partnerships between pharmaceutical, biotechnology, and clinical research companies are expected to propel the virtual clinical trials market development in the coming years. The rise in costs, combined with a higher rate of trail failures and an expansion in patient-centric trials, has resulted in a rise in demand to adopt technology in clinical trials. In fact, virtual clinical trials are expected to rise from high revenue to the highest revenue in the upcoming years. Still despite this development, for the majority of patients, getting clinical trials is still a difficult process, with enrollment and engagement presenting new challenges.

By Study Type

Based on Study Type, the market is segmented into Interventional, Observational, and Expanded Access and Others. The market was dominated by the interventional segment and represented the highest share of revenue in 2019. The fast growth in the number of experiments to create unique medications for different diseases and the modernization of labs are boosting the growth of this segment. The COVID-19 pandemic has fueled the demand for trials and testing of different new vaccines and drugs to fight situations all around the world, as conventional techniques of clinical trials accompany the massive danger of infection in individuals.

By Indication

Based on Indication, the market is segmented into Oncology, Cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and Other Indications. The market was dominated by the oncology segment and represented the highest share of revenue in 2019. The segment is also expected to add to the highest share of the revenue of the market during the forecast period. This is credited to the growing instances of cancer on a worldwide scale and the growing number of oncology clinical trials. Patients of cancer are the most unprotected during the outbreak of COVID-19.

By Region

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Europe represents the second-largest market share and is anticipated to observe promising growth opportunities in the next few years. Support from the government for R&D for the medicines and treatment for coming infectious diseases and chronic diseases, particularly in nations like Germany and U.K is a significant component boosting the growth of the regional market. Furthermore, the existence of leading players and benefits environment for carrying out clinical trials is another element anticipated to push the growth of the clinical trial market in Europe during the forecast period.

The major strategies followed by the market participants are Product Launches and Partnerships. Based on the Analysis presented in the Cardinal matrix; Oracle Corporation is the major forerunner in the Virtual Clinical Trials Market. Companies such as IQVIA Holdings, Inc., Dassault Systemes SE, and Medpace Holdings, Inc., are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., ICON PLC, Laboratory Corporation of America Holdings (Covance, Inc.), Dassault Systemes SE (Medidata Solutions, Inc.), Oracle Corporation, Parexel International Corporation (Pamplona Capital Management), PRA Health Sciences, Inc. (KKR & Co., Inc.), Medpace Holdings, Inc., Medable, Inc. and Clinical Ink, Inc. (G.I. Partners).

Recent strategies deployed in Virtual Clinical Trials Market

Partnerships, Collaborations, and Agreements:

Nov-2020: Parexel came into collaboration with the Clinical Trial Center (CTC). This collaboration will increase the research capacity of delivering early Phase clinical trials. It will also support the rising demand and continuation of early phase clinical studying during the pandemic.

Oct-2020: Oracle collaborated with FHI Clinical for improving the efficiency of the clinical trial and helped in getting therapies to market faster.

Aug-2020: Clinical Ink partnered with CRO, a company that provides support to the pharmaceutical, biotechnology, and medical device. The partnership helped eLAS to be successfully tested, perfected, and adapted for multiple uses in lupus clinical trials.

Jul-2020: IQVIA partnered with LMC Manna Research, Canada's largest network of fully-owned integrated sites. The partnership aimed to open its first Prime Site in Canada. This collaboration aimed to optimize processes and decrease the time taken to start clinical trials.

Jul-2020: IQVIA came into a partnership agreement with AstraZeneca PLC. This partnership aimed to develop vaccines and therapies against COVID-19, which come under US government projects. IQVIA aimed to enroll the U.S. study participants who received AZD1222 onto its virtual clinical trial platform.

Jul-2020: Medidata came into partnership with CTI, a leading contract research organization. The partnership provided trials for patients with rare and infectious diseases and cancer. CTI uses Medidata's Remote Source Reviewed to improve remote monitoring and document review for many global studies, including several COVID-19 projects.

Jul-2020: Oracle collaborated with The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Under this collaboration, Oracle developed a Cloud System called the CoVPN Volunteer Screening to identify and screen volunteers who wanted to participate in COVID-19 clinical trials.

Jun-2020: Parexel partnered with TriNetX, a global health research network. The partnership aimed to develop richer and actionable insights intended to increase the execution of clinical research. It enhanced access to real-world data and clinical trials with the faster delivery of new therapies.

Jun-2020: Medable partnered with LabCorp. This partnership allowed clinical trial participants to indulge with trials remotely which helped in decreasing patient drop-offs spurred by the pandemic.

Apr-2020: ICON extended its partnership for three years with Pfizer, an American multinational pharmaceutical corporation. This partnership aimed to provide a vast trial network and add global expertise in the planning, execution, and conduct of clinical trials.

Mar-2020: Medpace collaborated with Medidata. Following the collaboration, Medidata Rave Imaging integrated with Medpace's imaging systems and workflow. This created a seamless platform for capturing, managing, analyzing, and storing images and imaging data for clinical trials.

Oct-2019: Parexel partnered with Datavant, a developer of a healthcare data platform. It aimed to connect real-world data across the clinical trials Parexel conducts. This partnership integrated Datavant's connectivity technology into Parexel's standard data workflow for all studies. It connected the sponsors to real-world data with their clinical trial data.

Aug-2019: Oracle collaborated with HCL. It helped life sciences companies to execute and scale the next generation of digital clinical trials to decrease the time and cost of drug development.

Acquisition and Mergers:

Oct-2020: Medidata acquired MC10, a company focused on improving human health through digital solutions. The MC10 provided novel clinical analytics and biosensor capabilities to Medidata's existing Patient Cloud solutions. It improved Medidata's capabilities of integrating data from wearable sensors to help customers in successfully virtualized clinical trials.

Jul-2020: LabCorp took over GlobalCare, a globally recognized industry leader in patient-centric decentralized clinical trials (DCTs). This acquisition expanded the access and increased trials while improving trial resiliency.

Oct-2019: ICON acquired Symphony Clinical Research, a leading provider of at-home patient and site support services. It aimed to enhance the ICON's patient, site, and data strategy and complements ICON's existing PMG Research and MeDiNova Research site networks in the US and EMEA. It also reduced the travel cost for patients that broadened the ICON's recruitable population, provided patients access to clinical research studies.

Product Launches and Product Expansions:

Oct-2020: LabCorp improved the clinical trial experience to streamline the drug development process. This improvement enabled LabCorp to decentralized clinical trials for quick and efficient connection of patients to clinical trials.

Oct-2020: Medidata added myMedidata LIVE, a new feature on the myMedidata patient portal. It includes an advanced, intuitive platform for patients to allow flexible participation in clinical trials for new medicines and vaccines.

Sep-2020: ICON introduced Accellacare, a global clinical research network. It offers easier and faster access to treatments and deploys decentralized trials for the patients.

Sep-2020: Medable introduced Teleconsent, a part of its Telehealth family of cloud-based software. This software enabled fully virtual trials and allowed patients to handle the lengthy process of consenting from anywhere.

Jun-2020: LabCorp introduced COVID-19 Clinical Trial Connect in the U.S. A site designed to help people in accessing the information on how to participate in COVID-19 research. The Covid-19 clinical trial aimed to connect interested people in these clinical trials with sponsors to find solutions to the global pandemic.

Jun-2020: Oracle launched Clinical One Data Collection Cloud Service. It enabled to capture data from any source into one single and unified platform. It redefined technology to support clinical research for better efficiency and helped in the speedy delivery of the therapies.

May-2020: Parexel introduced #KeepingPatientsFirst integrated Real-World Evidence (RWE) research platform. It accelerates patient and physician access to insights on treatment and outcomes in COVID-19.

Apr-2020: IQVIA introduced the COVID-19 Trial Matching tool. It is designed to match every patient with specific clinical trials in the Covid-19 disease. The company created the first comprehensive online screener and trail matching tool for every U.S. Covid-19 trial.

Mar-2020: PRA Health Sciences expanded its industry by the introduction of the Mobile Health Platform. The platform allowed the sponsors to do everything in a physician's office or clinical site, virtually. This platform also added support for clinical trial sponsors and sites participating in clinical studies by helping them to connect and coordinating with patients.

Feb-2020: IQVIA launched its Avacare Clinical Research Network. It is a technology-based global site network that enhances the opportunity for more clinical trials. Avacare's distinctive analytical tools helped sites to match clinical trials quickly and effectively.

May-2019: ICON launched its web-based clinical trial patient engagement platform. It provided specific information and connectivity with the close investigative site. This platform added patient recruitment outreach by sites and expand the visibility of potential participants for sites and sponsors.

Scope of the Study

Market Segments Covered in the Report:

By Study Type

  • Interventional
  • Observational
  • Expanded Access
  • Others

By Indication

  • Oncology
  • Cardiovascular
  • Immunology
  • Gastrointestinal
  • Respiratory
  • Endocrinology
  • Ophthalmology
  • Other Indications

By Geography

  • North America

US

Canada

Mexico

Rest of North America

  • Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

  • Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

  • LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

  • IQVIA Holdings, Inc.
  • ICON PLC
  • Laboratory Corporation of America Holdings (Covance, Inc.)
  • Dassault Systemes SE (Medidata Solutions, Inc.)
  • Oracle Corporation
  • Parexel International Corporation (Pamplona Capital Management)
  • PRA Health Sciences, Inc. (KKR & Co., Inc.)
  • Medpace Holdings, Inc.
  • Medable, Inc.
  • Clinical Ink, Inc. (G.I. Partners)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Virtual Clinical Trials Market, by Study Type
    • 1.4.2 Global Virtual Clinical Trials Market, by Indication
    • 1.4.3 Global Virtual Clinical Trials Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Geographical Expansions
    • 3.2.4 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct - 2020, Nov) Leading Players
    • 3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun - 2020, Oct) Leading Players

Chapter 4. Global Virtual Clinical Trials Market by Study Type

  • 4.1 Global Interventional Market by Region
  • 4.2 Global Observational Market by Region
  • 4.3 Global Expanded Access Market by Region

Chapter 5. Global Virtual Clinical Trials Market by Indication

  • 5.1 Global Oncology Market by Region
  • 5.2 Global Cardiovascular Market by Region
  • 5.3 Global Immunology Market by Region
  • 5.4 Global Gastrointestinal Market by Region
  • 5.5 Global Respiratory Market by Region
  • 5.6 Global Endocrinology Market by Region
  • 5.7 Global Ophthalmology Market by Region
  • 5.8 Global Other Indications Market by Region

Chapter 6. Global Virtual Clinical Trials Market by Region

  • 6.1 North America Virtual Clinical Trials Market
    • 6.1.1 North America Virtual Clinical Trials Market by Study Type
      • 6.1.1.1 North America Interventional Market by Country
      • 6.1.1.2 North America Observational Market by Country
      • 6.1.1.3 North America Expanded Access Market by Country
      • 6.1.1.4 North America Virtual Clinical Trials Market by Indication
      • 6.1.1.5 North America Oncology Market by Country
      • 6.1.1.6 North America Cardiovascular Market by Country
      • 6.1.1.7 North America Immunology Market by Country
      • 6.1.1.8 North America Gastrointestinal Market by Country
      • 6.1.1.9 North America Respiratory Market by Country
      • 6.1.1.10 North America Endocrinology Market by Country
      • 6.1.1.11 North America Ophthalmology Market by Country
      • 6.1.1.12 North America Other Indications Market by Country
    • 6.1.2 North America Virtual Clinical Trials Market by Country
      • 6.1.2.1 US Virtual Clinical Trials Market
        • 6.1.2.1.1 US Virtual Clinical Trials Market by Study Type
        • 6.1.2.1.2 US Virtual Clinical Trials Market by Indication
      • 6.1.2.2 Canada Virtual Clinical Trials Market
        • 6.1.2.2.1 Canada Virtual Clinical Trials Market by Study Type
        • 6.1.2.2.2 Canada Virtual Clinical Trials Market by Indication
      • 6.1.2.3 Mexico Virtual Clinical Trials Market
        • 6.1.2.3.1 Mexico Virtual Clinical Trials Market by Study Type
        • 6.1.2.3.2 Mexico Virtual Clinical Trials Market by Indication
      • 6.1.2.4 Rest of North America Virtual Clinical Trials Market
        • 6.1.2.4.1 Rest of North America Virtual Clinical Trials Market by Study Type
        • 6.1.2.4.2 Rest of North America Virtual Clinical Trials Market by Indication
  • 6.2 Europe Virtual Clinical Trials Market
    • 6.2.1 Europe Virtual Clinical Trials Market by Study Type
      • 6.2.1.1 Europe Interventional Market by Country
      • 6.2.1.2 Europe Observational Market by Country
      • 6.2.1.3 Europe Expanded Access Market by Country
    • 6.2.2 Europe Virtual Clinical Trials Market by Indication
      • 6.2.2.1 Europe Oncology Market by Country
      • 6.2.2.2 Europe Cardiovascular Market by Country
      • 6.2.2.3 Europe Immunology Market by Country
      • 6.2.2.4 Europe Gastrointestinal Market by Country
      • 6.2.2.5 Europe Respiratory Market by Country
      • 6.2.2.6 Europe Endocrinology Market by Country
      • 6.2.2.7 Europe Ophthalmology Market by Country
      • 6.2.2.8 Europe Other Indications Market by Country
    • 6.2.3 Europe Virtual Clinical Trials Market by Country
      • 6.2.3.1 Germany Virtual Clinical Trials Market
        • 6.2.3.1.1 Germany Virtual Clinical Trials Market by Study Type
        • 6.2.3.1.2 Germany Virtual Clinical Trials Market by Indication
      • 6.2.3.2 UK Virtual Clinical Trials Market
        • 6.2.3.2.1 UK Virtual Clinical Trials Market by Study Type
        • 6.2.3.2.2 UK Virtual Clinical Trials Market by Indication
      • 6.2.3.3 France Virtual Clinical Trials Market
        • 6.2.3.3.1 France Virtual Clinical Trials Market by Study Type
        • 6.2.3.3.2 France Virtual Clinical Trials Market by Indication
      • 6.2.3.4 Russia Virtual Clinical Trials Market
        • 6.2.3.4.1 Russia Virtual Clinical Trials Market by Study Type
        • 6.2.3.4.2 Russia Virtual Clinical Trials Market by Indication
      • 6.2.3.5 Spain Virtual Clinical Trials Market
        • 6.2.3.5.1 Spain Virtual Clinical Trials Market by Study Type
        • 6.2.3.5.2 Spain Virtual Clinical Trials Market by Indication
      • 6.2.3.6 Italy Virtual Clinical Trials Market
        • 6.2.3.6.1 Italy Virtual Clinical Trials Market by Study Type
        • 6.2.3.6.2 Italy Virtual Clinical Trials Market by Indication
      • 6.2.3.7 Rest of Europe Virtual Clinical Trials Market
        • 6.2.3.7.1 Rest of Europe Virtual Clinical Trials Market by Study Type
        • 6.2.3.7.2 Rest of Europe Virtual Clinical Trials Market by Indication
  • 6.3 Asia Pacific Virtual Clinical Trials Market
    • 6.3.1 Asia Pacific Virtual Clinical Trials Market by Study Type
      • 6.3.1.1 Asia Pacific Interventional Market by Country
      • 6.3.1.2 Asia Pacific Observational Market by Country
      • 6.3.1.3 Asia Pacific Expanded Access Market by Country
    • 6.3.2 Asia Pacific Virtual Clinical Trials Market by Indication
      • 6.3.2.1 Asia Pacific Oncology Market by Country
      • 6.3.2.2 Asia Pacific Cardiovascular Market by Country
      • 6.3.2.3 Asia Pacific Immunology Market by Country
      • 6.3.2.4 Asia Pacific Gastrointestinal Market by Country
      • 6.3.2.5 Asia Pacific Respiratory Market by Country
      • 6.3.2.6 Asia Pacific Endocrinology Market by Country
      • 6.3.2.7 Asia Pacific Ophthalmology Market by Country
      • 6.3.2.8 Asia Pacific Other Indications Market by Country
    • 6.3.3 Asia Pacific Virtual Clinical Trials Market by Country
      • 6.3.3.1 China Virtual Clinical Trials Market
        • 6.3.3.1.1 China Virtual Clinical Trials Market by Study Type
        • 6.3.3.1.2 China Virtual Clinical Trials Market by Indication
      • 6.3.3.2 Japan Virtual Clinical Trials Market
        • 6.3.3.2.1 Japan Virtual Clinical Trials Market by Study Type
        • 6.3.3.2.2 Japan Virtual Clinical Trials Market by Indication
      • 6.3.3.3 India Virtual Clinical Trials Market
        • 6.3.3.3.1 India Virtual Clinical Trials Market by Study Type
        • 6.3.3.3.2 India Virtual Clinical Trials Market by Indication
      • 6.3.3.4 South Korea Virtual Clinical Trials Market
        • 6.3.3.4.1 South Korea Virtual Clinical Trials Market by Study Type
        • 6.3.3.4.2 South Korea Virtual Clinical Trials Market by Indication
      • 6.3.3.5 Singapore Virtual Clinical Trials Market
        • 6.3.3.5.1 Singapore Virtual Clinical Trials Market by Study Type
        • 6.3.3.5.2 Singapore Virtual Clinical Trials Market by Indication
      • 6.3.3.6 Malaysia Virtual Clinical Trials Market
        • 6.3.3.6.1 Malaysia Virtual Clinical Trials Market by Study Type
        • 6.3.3.6.2 Malaysia Virtual Clinical Trials Market by Indication
      • 6.3.3.7 Rest of Asia Pacific Virtual Clinical Trials Market
        • 6.3.3.7.1 Rest of Asia Pacific Virtual Clinical Trials Market by Study Type
        • 6.3.3.7.2 Rest of Asia Pacific Virtual Clinical Trials Market by Indication
  • 6.4 LAMEA Virtual Clinical Trials Market
    • 6.4.1 LAMEA Virtual Clinical Trials Market by Study Type
      • 6.4.1.1 LAMEA Interventional Market by Country
      • 6.4.1.2 LAMEA Observational Market by Country
      • 6.4.1.3 LAMEA Expanded Access Market by Country
    • 6.4.2 LAMEA Virtual Clinical Trials Market by Indication
      • 6.4.2.1 LAMEA Oncology Market by Country
      • 6.4.2.2 LAMEA Cardiovascular Market by Country
      • 6.4.2.3 LAMEA Immunology Market by Country
      • 6.4.2.4 LAMEA Gastrointestinal Market by Country
      • 6.4.2.5 LAMEA Respiratory Market by Country
      • 6.4.2.6 LAMEA Endocrinology Market by Country
      • 6.4.2.7 LAMEA Ophthalmology Market by Country
      • 6.4.2.8 LAMEA Other Indications Market by Country
    • 6.4.3 LAMEA Virtual Clinical Trials Market by Country
      • 6.4.3.1 Brazil Virtual Clinical Trials Market
        • 6.4.3.1.1 Brazil Virtual Clinical Trials Market by Study Type
        • 6.4.3.1.2 Brazil Virtual Clinical Trials Market by Indication
      • 6.4.3.2 Argentina Virtual Clinical Trials Market
        • 6.4.3.2.1 Argentina Virtual Clinical Trials Market by Study Type
        • 6.4.3.2.2 Argentina Virtual Clinical Trials Market by Indication
      • 6.4.3.3 UAE Virtual Clinical Trials Market
        • 6.4.3.3.1 UAE Virtual Clinical Trials Market by Study Type
        • 6.4.3.3.2 UAE Virtual Clinical Trials Market by Indication
      • 6.4.3.4 Saudi Arabia Virtual Clinical Trials Market
        • 6.4.3.4.1 Saudi Arabia Virtual Clinical Trials Market by Study Type
        • 6.4.3.4.2 Saudi Arabia Virtual Clinical Trials Market by Indication
      • 6.4.3.5 South Africa Virtual Clinical Trials Market
        • 6.4.3.5.1 South Africa Virtual Clinical Trials Market by Study Type
        • 6.4.3.5.2 South Africa Virtual Clinical Trials Market by Indication
      • 6.4.3.6 Nigeria Virtual Clinical Trials Market
        • 6.4.3.6.1 Nigeria Virtual Clinical Trials Market by Study Type
        • 6.4.3.6.2 Nigeria Virtual Clinical Trials Market by Indication
      • 6.4.3.7 Rest of LAMEA Virtual Clinical Trials Market
        • 6.4.3.7.1 Rest of LAMEA Virtual Clinical Trials Market by Study Type
        • 6.4.3.7.2 Rest of LAMEA Virtual Clinical Trials Market by Indication

Chapter 7. Company Profiles

  • 7.1 IQVIA Holdings, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Recent strategies and developments:
      • 7.1.4.1 Partnerships, Collaborations, and Agreements:
      • 7.1.4.2 Product Launches and Product Expansions:
  • 7.2 ICON PLC
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.1 Recent strategies and developments:
      • 7.2.1.1 Partnerships, Collaborations, and Agreements:
      • 7.2.1.2 Product Launches and Product Expansions:
      • 7.2.1.3 Acquisition and Mergers:
  • 7.3 Laboratory Corporation of America Holdings (Covance, Inc.)
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Recent strategies and developments:
      • 7.3.4.1 Product Launches and Product Expansions:
      • 7.3.4.2 Acquisition and Mergers:
  • 7.4 Dassault Systemes SE (Medidata Solutions, Inc.)
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Partnerships, Collaborations, and Agreements:
      • 7.4.5.2 Product Launches and Product Expansions:
      • 7.4.5.3 Acquisition and Mergers:
  • 7.5 Oracle Corporation
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Partnerships, Collaborations, and Agreements:
      • 7.5.5.2 Product Launches and Product Expansions:
  • 7.6 Parexel International Corporation (Pamplona Capital Management)
    • 7.6.1 Company Overview
    • 7.6.2 Recent strategies and developments:
      • 7.6.2.1 Partnerships, Collaborations, and Agreements:
      • 7.6.2.2 Product Launches and Product Expansions:
      • 7.6.2.3 Geographical Expansions:
  • 7.7 PRA Health Sciences, Inc. (KKR & Co., Inc.)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental Analysis
    • 7.7.4 Recent strategies and developments:
      • 7.7.4.1 Partnerships, Collaborations, and Agreements:
      • 7.7.4.2 Product Launches and Product Expansions:
  • 7.8 Medpace Holdings, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Recent strategies and developments:
      • 7.8.3.1 Partnerships, Collaborations, and Agreements:
  • 7.9 Medable, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Recent strategies and developments:
      • 7.9.2.1 Partnerships, Collaborations, and Agreements:
      • 7.9.2.2 Product Launches and Product Expansions:
  • 7.10. Clinical Ink, Inc. (G.I. Partners)
    • 7.10.1 Company Overview
    • 7.10.2 Recent strategies and developments:
      • 7.10.2.1 Partnerships, Collaborations, and Agreements:
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.